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Abstract
In support of ongoing anti-microbial & anti-tumor research,
analogs of a GVSU lead compound, a derivative of the known
telomerase inhibitor BIBR1532, were synthesized. These
compounds were submitted for biological analysis to determine
pharmacological activity toward the discovery of either an
antibiotic that can resist bacterial enzymatic degradation or a
chemotherapeutic molecule that can destroy tumors cells
without increasing toxicity. The anti-microbial interest in these
compounds was based on the fact that they are non-penicillin
based antibiotics and display a broad range of efficacy against
targeted bacteria, including C-Diff & MRSA, with minimal
toxicity. Although the compounds presented in this poster were
not biologically active, the general interest in these molecules
was based on the efficacy of the aforementioned antibiotics.
The compounds displayed here were made via nucleophilic acyl
substitution chemistry, where various substituted anthranilic
acid molecules were coupled via a condensation reaction with
either commercially available or synthetically made acid
chlorides. Characterization of these compounds was
accomplished by TLC, IR, & 1H-NMR analysis.
Introduction
• b-lactam antibiotics are chemotherapeutic agents, containing
highly strained four-carbon lactam rings, along with a reactive
amide group, within the ring.1
• Because of this reactive moiety, they are subject to
degradation, as a result of antibacterial resistance.2
• The mechanism for b-lactams is that they target penicillin-
binding proteins (PBPs), which catalyze peptidoglycan cross-
linking.3
• b-lactamases are robust enzymes that undermine b-lactams,
due to their ability to cause bacterial resistance.2
• Due to the degradative nature of these enzymes, innovative
research is underway, developing novel non-penicillin based
antibiotics with low toxicity, where the molecular structure is
not impaired by the machinery of bacterial enzymatic
resistance.
• The focus of this research, is the synthesis of compounds,
where the newly formed aromatic amide is substituted with
functional groups possesing the ability to inhibit the
mechanisms of bacterial resistance to antibiotics.
Data from Fry, 1996
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Conclusion
Although the aforementioned compounds did not exhibit
biological activity, upon submission to Dr. Roderick Morgan for
testing, future work will investigate nucleophilic acyl
substitution using various alkyl-substituted cinnamic acid
groups.
Synthetic Mechanism
Figure 1: Synthetic Mechanism for Condensation Reactions. Compounds were synthesized
via nucleophilic acyl substitution chemistry. The mechanism displayed above is the
formation of NMH41_Octanoyl, as the acid chloride & the derivatized anthranilic acid
compound(s) react to make the final aromatic amide product.
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Figure 2: 1H-NMR Data, JEOL 400 MHz, DMSO. The 1H-NMR data above represents the chemical
shift, integration, & splitting for the following molecules: NMH 41_Octanoyl, NMH 49_Nonanoyl,
NMH 53_Decanoyl, & NMH 59_Lauroyl.
Figure 3: 1H-NMR Data, JEOL 400 MHz, DMSO. The 1H-NMR data above represents the chemical
shift, integration, & splitting for the following molecule: NMH 56_10-Undecenoyl. Hydrogens f, g, &
h exhibited geminal splitting of cis/trans protons on an alkene.
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Hydrogen 
Atom
Chemical 
Shift
(ppm)
Integration Splitting J Value (Hz)
a 7.27 1 dd 7.56
b 7.36 1 t 7.92
c 7.43 1 dd 8.36
d 9.58 1 s -
e 2.24 2 tt 7.60
f = alkene pending 1 pending pending
g = alkene pending 1 pending pending
h = alkene pending 1 pending pending
Hydrogen 
Atom
Chemical 
Shift
(ppm)
Integration Splitting J Value (Hz)
a 7.28 1 dd 1.4, 7.96
b 7.36 1 t 7.84
c 7.42 1 dd 1.36, 8.24
d 9.58 1 s -
e 2.23 2 tt 7.36
f 0.82 3 tt 6.72
